Long-term remission of locally recurrent oropharyngeal cancer after docetaxel-based chemotherapy plus cetuximab.

about

Long-term remission of locally recurrent oropharyngeal cancer after docetaxel-based chemotherapy plus cetuximab.

Item

http://www.wikidata.org/entity/Q48036615

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Long-term remission of locally ...... d chemotherapy plus cetuximab.

@en

Long-term remission of locally ...... d chemotherapy plus cetuximab.

@nl

type

Item

label

Long-term remission of locally ...... d chemotherapy plus cetuximab.

@en

Long-term remission of locally ...... d chemotherapy plus cetuximab.

@nl

prefLabel

Long-term remission of locally ...... d chemotherapy plus cetuximab.

@en

Long-term remission of locally ...... d chemotherapy plus cetuximab.

@nl

P1476

Long-term remission of locally ...... d chemotherapy plus cetuximab.

@en

P2093

Bob Corthouts

http://www.w3.org/2001/XMLSchema#string

Carl Van Laer

http://www.w3.org/2001/XMLSchema#string

Danielle Van Den Weyngaert

http://www.w3.org/2001/XMLSchema#string

Eric Van Marck

http://www.w3.org/2001/XMLSchema#string

Jan B Vermorken

http://www.w3.org/2001/XMLSchema#string

Laurens Carp

http://www.w3.org/2001/XMLSchema#string

Petr Szturz

http://www.w3.org/2001/XMLSchema#string

P2860

Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival.

Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial.

Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer group.

Mutation analysis of genes in the EGFR pathway in Head and Neck cancer patients: implications for anti-EGFR treatment response

Platinum-based chemotherapy plus cetuximab in head and neck cancer.

Circulating tumor cells in patients with recurrent or metastatic head and neck carcinoma: prognostic and predictive significance

The association between EGFR variant III, HPV, p16, c-MET, EGFR gene copy number and response to EGFR inhibitors in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.

Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes.

Optimal treatment for recurrent/metastatic head and neck cancer.

Management of recurrent head and neck cancer: recent progress and future directions.

P2888

s00405-015-3673-y

P304

1629-1636

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00405-015-3673-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

273

http://www.w3.org/2001/XMLSchema#string

P50

Olivier M. Vanderveken

Pol Specenier

P577

2015-06-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277779434

http://www.w3.org/2001/XMLSchema#string

P698

26044403

http://www.w3.org/2001/XMLSchema#string

P921

cetuximab